|
|
|
Volumn 20, Issue 4, 2007, Pages
|
|
Challenges in the anticipation of biosimilars: How must a P&T committee gear up?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
GENERIC DRUG;
GROWTH HORMONE;
INSULIN;
INTERFERON;
COST CONTROL;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MARKETING;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH INSURANCE;
LAW;
ORGANIZATION;
PHARMACY AND THERAPEUTICS COMMITTEE;
SHORT SURVEY;
DRUG APPROVAL;
DRUGS, GENERIC;
FORMULARIES;
HUMANS;
PHARMACY AND THERAPEUTICS COMMITTEE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 34247385181
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
